Rahul D. Ballal Agios Pharmaceuticals, Inc. (AGIO) insider trading activity

Rahul D. Ballal is Director of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 10,112 shares of AGIO, which is worth approximately $401,041. The most recent transaction as insider was on Jun 20, 2025, when has been sold 2,120 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.1K

26.53% 3M change

77.72% 12M change

Total Value Held $401,041

Rahul D. Ballal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 20 2025	BUY Exercise of conversion of derivative security	-	2,120 Added 17.33%	10,112 Common Stock
Nov 08 2024	SELL Open market or private sale	$583,400 $58.34 p/Share	10,000 Reduced 55.58%	7,992 Common Stock
Nov 08 2024	BUY Exercise of conversion of derivative security	$259,899 $25.99 p/Share	10,000 Added 35.72%	17,992 Common Stock
Nov 07 2024	SELL Open market or private sale	$538,700 $53.87 p/Share	10,000 Reduced 55.58%	7,992 Common Stock
Nov 07 2024	BUY Exercise of conversion of derivative security	$259,899 $25.99 p/Share	10,000 Added 35.72%	17,992 Common Stock
Aug 11 2024	BUY Exercise of conversion of derivative security	-	2,302 Added 22.36%	7,992 Common Stock
Jun 13 2024	BUY Exercise of conversion of derivative security	-	3,388 Added 37.32%	5,690 Common Stock
Aug 11 2023	BUY Exercise of conversion of derivative security	-	2,302 Added 50.0%	2,302 Common Stock

Also insider at

IMRA

IMARA Inc. Healthcare

RDB

Rahul D. Ballal

Director

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Value

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Track Activities on AGIO

Account